100s of titles, one news app for just $10 a month.
Dive Deeper:
Earnings Preview: Fulcrum Therapeutics
Fulcrum Therapeutics (NASDAQ:FULC) is set to give its latest quarterly earnings report on Monday, 2022-05-09. Here's what investors need to…
Preview: BioXcel Therapeutics's Earnings
BioXcel Therapeutics (NASDAQ:BTAI) is set to give its latest quarterly earnings report on Monday, 2022-05-09. Here's what investors need to…
Preview: Forma Therapeutics Hldgs's Earnings
Forma Therapeutics Hldgs (NASDAQ:FMTX) is set to give its latest quarterly earnings report on Friday, 2022-05-06. Here's what investors need…
A Preview Of Nabriva Therapeutics's Earnings
Nabriva Therapeutics (NASDAQ:NBRV) is set to give its latest quarterly earnings report on Thursday, 2022-05-05. Here's what investors need to…
One subscription that gives you access to news from hundreds of sites
Earnings Outlook For Amicus Therapeutics
Amicus Therapeutics (NASDAQ:FOLD) is set to give its latest quarterly earnings report on Monday, 2022-05-09. Here's what investors need to…
Preview: Corcept Therapeutics's Earnings
Corcept Therapeutics (NASDAQ:CORT) is set to give its latest quarterly earnings report on Thursday, 2022-05-05. Here's what investors need to…
Get all your news in one place
Latest Business news:
Bitcoin Recovers After Longest Run of Weekly Losses Since 2011
Bitcoin recovered to trade just above the $30,000 level where it’s been mostly hovering since the collapse of the TerraUSD…
Read news from The Economist, FT, Bloomberg and more, with one subscription
Learn More
How to Make Money (or Even Get Rich) During a Stock Market Crash
A crash creates buying opportunities if you can develop the right mindset.
HSBC suspends head of responsible investing who called climate warnings ‘shrill’
Bank investigating Stuart Kirk’s conference speech deriding flooding risks and climate warnings from UN and Bank of England
John O'Neill to front Star casino inquiry
Star Entertainment Group executive chairman John O'Neill is scheduled to appear at the gaming inquiry into its suitability to operate…
After $5 Trillion Rout, Emerging Markets Seek Turnaround Signal
The wreckage of a $5 trillion rout in emerging markets is starting to look like a buying opportunity to some…
From analysis to good news, read the world’s best news in one place
New Zealand PM Ardern to visit U.S. to boost exports, lure tourists
New Zealand Prime Minister Jacinda Ardern will visit the United States this week in a bid to boost exports and…
Rod Sims says Facebook should be forced to negotiate with SBS under news media bargaining code
Despite dozens of deals to pay Australian news publishers for content, social media company has left out SBS and the…

A Preview Of Adaptimmune Therapeutics's Earnings

By Benzinga Insights

Adaptimmune Therapeutics (NASDAQ:ADAP) is set to give its latest quarterly earnings report on Monday, 2022-05-09. Here's what investors need to know before the announcement.

Analysts estimate that Adaptimmune Therapeutics will report an earnings per share (EPS) of $-0.22.

Adaptimmune Therapeutics bulls will hope to hear the company to announce they've not only beaten that estimate, but also to provide positive guidance, or forecasted growth, for the next quarter.

New investors should note that it is sometimes not an earnings beat or miss that most affects the price of a stock, but the guidance (or forecast).

Historical Earnings Performance

Last quarter the company missed EPS by $0.18, which was followed by a 4.95% drop in the share price the next day.

Here's a look at Adaptimmune Therapeutics's past performance and the resulting price change:

Quarter Q4 2021 Q3 2021 Q2 2021 Q1 2021
EPS Estimate 0.14 -0.26 -0.24 -0.25
EPS Actual -0.04 -0.30 -0.24 -0.24
Price Change % -4.95% 4.19% 3.48% -2.45%

Stock Performance

Shares of Adaptimmune Therapeutics were trading at $1.78 as of May 05. Over the last 52-week period, shares are down 63.09%. Given that these returns are generally negative, long-term shareholders are likely unhappy going into this earnings release.

To track all earnings releases for Adaptimmune Therapeutics visit their earnings calendar on our site.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

What is inkl?
The world’s most important news, from 100+ trusted global sources, in one place.
Morning Edition
Your daily
news overview

Morning Edition ensures you start your day well informed.

No paywalls, no clickbait, no ads
Enjoy beautiful reading

Content is only half the story. The world's best news experience is free from distraction: ad-free, clickbait-free, and beautifully designed.

Expert Curation
The news you need to know

Stories are ranked by proprietary algorithms based on importance and curated by real news journalists to ensure that you receive the most important stories as they break.

Dive Deeper:
Earnings Preview: Fulcrum Therapeutics
Fulcrum Therapeutics (NASDAQ:FULC) is set to give its latest quarterly earnings report on Monday, 2022-05-09. Here's what investors need to…
Preview: BioXcel Therapeutics's Earnings
BioXcel Therapeutics (NASDAQ:BTAI) is set to give its latest quarterly earnings report on Monday, 2022-05-09. Here's what investors need to…
Preview: Forma Therapeutics Hldgs's Earnings
Forma Therapeutics Hldgs (NASDAQ:FMTX) is set to give its latest quarterly earnings report on Friday, 2022-05-06. Here's what investors need…
A Preview Of Nabriva Therapeutics's Earnings
Nabriva Therapeutics (NASDAQ:NBRV) is set to give its latest quarterly earnings report on Thursday, 2022-05-05. Here's what investors need to…
One subscription that gives you access to news from hundreds of sites
Earnings Outlook For Amicus Therapeutics
Amicus Therapeutics (NASDAQ:FOLD) is set to give its latest quarterly earnings report on Monday, 2022-05-09. Here's what investors need to…
Preview: Corcept Therapeutics's Earnings
Corcept Therapeutics (NASDAQ:CORT) is set to give its latest quarterly earnings report on Thursday, 2022-05-05. Here's what investors need to…
Get all your news in one place